A law that coaxed companies to lower the price of drugs came with a little-known consequence: smaller discounts for ...

While this option may be less expensive and seems convenient, it’s best to consult a doctor about dosage if you use it, says Joshua J. Neumiller, CDCES, PharmD, the president elect of ...

Insulin is a lifesaving product for many individuals living with diabetes - it's also incredibly expensive. Some patients haven't been able to afford their prescriptions, or have been forced to ...

In a report released today, Joanne Wuensch from Citi reiterated a Buy rating on Insulet (PODD – Research Report). The company’s shares closed ...

With an increased confidence in the company’s prospects, HSBC raised its earnings estimates for Biocon, projecting ...

Frantz said the price of insulin is drastic when compared with how much it costs in other parts of the world. “If you were to buy Ozempic — and Ozempic is one of the insulin drugs we’re ...

Bernstein analyst Lee Hambright maintained a Buy rating on Tandem Diabetes Care (TNDM – Research Report) yesterday and set a price target of ...